Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-16 Purchase |
2022-06-17 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
8,000 | $7.13 | $57,040 | 2,683,886 (Direct) |
View |
| 2022-06-14 Purchase |
2022-06-15 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
12,000 | $7.91 | $94,920 | 2,675,886 (Direct) |
View |
| 2022-06-10 Purchase |
2022-06-13 06:04 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
12,000 | $8.33 | $99,960 | 2,663,886 (Direct) |
View |
| 2022-06-09 Purchase |
2022-06-10 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
4,500 | $10.9 | $49,050 | 1,243,453 (Direct) |
View |
| 2022-06-07 Purchase |
2022-06-08 06:07 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
6,000 | $8.55 | $51,300 | 1,238,953 (Direct) |
View |
| 2022-06-03 Purchase |
2022-06-06 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
9,250 | $8.35 | $77,238 | 1,232,953 (Direct) |
View |
| 2022-06-02 Purchase |
2022-06-03 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
6,774 | $7.38 | $49,992 | 1,223,703 (Direct) |
View |
| 2022-04-25 Purchase |
2022-04-26 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Daugherty Frank Joseph Chief Medical Officer |
1,000 | $16.25 | $16,250 | 90,121 (Direct) |
View |
| 2022-04-21 Purchase |
2022-04-22 06:04 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
6,000 | $16.09 | $96,540 | 1,216,929 (Direct) |
View |
| 2022-04-19 Purchase |
2022-04-21 06:03 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
6,000 | $16.74 | $100,440 | 1,210,929 (Direct) |
View |
| 2022-04-19 Purchase |
2022-04-20 06:02 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
500 | $16.74 | $8,370 | 255,995 (Direct) |
View |
| 2022-02-11 Purchase |
2022-02-14 06:06 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
5,500 | $19.8 | $108,900 | 1,204,929 (Direct) |
View |
| 2022-02-04 Purchase |
2022-02-08 06:02 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
5,000 | $19.59 | $97,950 | 1,199,429 (Direct) |
View |
| 2022-01-31 Purchase |
2022-02-01 06:01 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
500 | $18.47 | $9,235 | 255,495 (Direct) |
View |
| 2022-01-21 Purchase |
2022-01-24 06:08 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
500 | $16.33 | $8,165 | 254,995 (Direct) |
View |
| 2022-01-21 Purchase |
2022-01-24 06:08 am |
Greenwich LifeSciences Inc. | GLSI | Hallock Kenneth Director |
300 | $16.32 | $4,896 | 397,304 (Direct) |
View |
| 2022-01-18 Purchase |
2022-01-19 06:09 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg. Affairs |
500 | $18.87 | $9,435 | 254,495 (Direct) |
View |
| 2022-01-13 Purchase |
2022-01-18 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,000 | $19.99 | $19,990 | 1,194,429 (Direct) |
View |
| 2022-01-13 Purchase |
2022-01-14 06:06 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg. Affairs |
1,000 | $19.99 | $19,990 | 253,995 (Direct) |
View |
| 2022-01-13 Purchase |
2022-01-14 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Daugherty Frank Joseph Chief Medical Officer |
1,000 | $19.99 | $19,990 | 89,121 (Direct) |
View |
| 2022-01-03 Purchase |
2022-01-04 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,050 | $23.82 | $48,831 | 1,193,429 (Direct) |
View |
| 2021-12-14 Purchase |
2021-12-16 06:08 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,840 | $27.17 | $49,992 | 1,191,379 (Direct) |
View |
| 2021-12-14 Purchase |
2021-12-16 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Daugherty Frank Joseph Chief Medical Officer |
1,111 | $26.99 | $29,983 | 88,121 (Direct) |
View |
| 2021-12-14 Purchase |
2021-12-16 06:02 am |
Greenwich LifeSciences Inc. | GLSI | McWilliams David Director |
200 | $27.56 | $5,512 | 620,301 (Direct) |
View |
| 2021-04-13 Purchase |
2021-04-14 07:30 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO |
2,700 | $36.98 | $99,853 | 7,782,458 (Indirect Direct) |
View |
| 2020-11-24 Purchase |
2020-11-27 07:00 am |
Greenwich LifeSciences Inc. | GLSI | Hallock Kenneth Director |
1,000 | $5.386 | $5,386 | 397,004 (Indirect) |
View |
| 2020-11-23 Purchase |
2020-11-25 07:00 am |
Greenwich LifeSciences Inc. | GLSI | Daugherty Frank Joseph Chief Medical Officer |
1,000 | $5.1 | $5,100 | 87,010 (Direct) |
View |
| 2020-11-20 Purchase |
2020-11-24 08:00 am |
Greenwich LifeSciences Inc. | GLSI | McWilliams David Director |
1,500 | $5.4 | $8,100 | 620,101 (Direct) |
View |
| 2020-11-20 Purchase |
2020-11-24 08:00 am |
Greenwich LifeSciences Inc. | GLSI | Hallock Kenneth Director |
1,000 | $5.37 | $5,370 | 396,004 (Indirect) |
View |
| 2020-11-20 Purchase |
2020-11-24 08:00 am |
Greenwich LifeSciences Inc. | GLSI | Rothe Eric Director |
2,000 | $5.4 | $10,800 | 313,226 (Direct) |
View |
| 2020-11-19 Purchase |
2020-11-20 07:00 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO |
2,000 | $5.3977 | $10,795 | 7,779,758 (Indirect Direct) |
View |
| 2020-09-29 Purchase |
2020-10-01 08:00 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO |
16,667 | $4.6025 | $76,710 | 7,777,758 (Indirect Direct) |
View |
| 2020-09-29 Purchase |
2020-10-01 08:00 am |
Greenwich LifeSciences Inc. | GLSI | Hallock Kenneth Director |
8,333 | $4.6025 | $38,353 | 395,004 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-01-11 06:05 am |
N/A N/A |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical & Reg. Affairs |
0 | $0 | 252,995 (Direct) |
View |
| 2020-11-10 Other |
2020-11-27 07:00 am |
N/A N/A |
Greenwich LifeSciences Inc. | GLSI | Patel Pankaj Amrit 10% Owner |
187,266 | $0 | 561,798 (Direct) |
View |
| 2020-09-29 Exercise |
2020-10-09 6:02 pm |
N/A N/A |
Greenwich LifeSciences Inc. | GLSI | Patel Kinnary 10% Owner |
182,020 | $0 | 5,192,178 (Indirect) |
View |
| 2020-09-29 Other |
2020-10-09 6:02 pm |
N/A N/A |
Greenwich LifeSciences Inc. | GLSI | Patel Kinnary 10% Owner |
7,292 | $0 | 5,192,178 (Indirect) |
View |
Ownership |
2020-10-09 6:00 pm |
N/A N/A |
Greenwich LifeSciences Inc. | GLSI | Patel Kinnary 10% Owner |
0 | $0 | 5,177,594 (Indirect) |
View |
Ownership(A) |
2020-09-30 9:02 pm |
N/A N/A |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical & Reg Affairs |
0 | $0 | 252,810 (Direct) |
View |
| 2020-09-29 Exercise |
2020-09-30 9:01 pm |
N/A N/A |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO |
1,871,656 | $0 | 6,381,680 (Direct) |
View |
| 2020-09-29 Other |
2020-09-30 9:01 pm |
N/A N/A |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO |
28,622 | $0 | 6,381,680 (Direct) |
View |
| 2020-09-29 Exercise |
2020-09-30 9:00 pm |
N/A N/A |
Greenwich LifeSciences Inc. | GLSI | Hallock Kenneth Director |
129,303 | $0 | 399,399 (Indirect) |
View |
| 2020-09-29 Other |
2020-09-30 9:00 pm |
N/A N/A |
Greenwich LifeSciences Inc. | GLSI | Hallock Kenneth Director |
12,728 | $0 | 399,399 (Indirect) |
View |